FIELD: medicine.
SUBSTANCE: method involves an intraperitoneal administration of N-acetyl-β-1-O-heptylmuramyl-L-alanyl-D-isoglutamine 20 mcg in 0.9% NaCl 0.1 ml per female laboratory mouse. The preparation is administered on the 5th day of pregnancy in a period of blastocyst implantation and on the 7th day in the beginning of a placentation period.
EFFECT: high level of embryo resorption, high model reproducibility and applicability of linear and non-linear animals.
3 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR IMMUNOPATHOLOGICAL PLACENTAL INSUFFICIENCY SIMULATION | 2021 |
|
RU2763837C1 |
| CHEMICAL COMPOUND TETRASUBSTITUTED WITH GLYCOLIC ACID PICEATANNOL (E)-2,2'-((4-(3,5-BIS(CARBOXYLATOMETHOXY)STYRYL)-1,2-PHENYLENE)BIS(OXY)) DIACETATE, PHARMACEUTICAL COMPOSITION AND ITS USE FOR TREATING SYSTEMIC INFLAMMATORY DISEASES AND CONDITIONS, INCLUDING ACUTE RESPIRATORY DISTRESS SYNDROME | 2023 |
|
RU2826492C1 |
| REMEDY WITH ANTI-TUMOR EFFECT FOR TREATMENT OF ONCOLOGICAL DISEASES | 2018 |
|
RU2761429C2 |
| METHOD FOR SYNCHRONIZING THE ESTROUS CYCLE IN FEMALE MICE IN EXPERIMENT | 2021 |
|
RU2761137C1 |
| METHOD FOR PREVENTING AND TREATING TRANSPLANT- HOST RESPONSE BY STIMULATING ANTI-IDIOTYPIC SUPPRESSION OF DONOR LYMPHOCYTES IN EXPERIMENTAL MODEL | 1999 |
|
RU2175246C2 |
| AGENT FOR CORRECTING AUTISM SPECTRUM DISORDERS | 2017 |
|
RU2666598C1 |
| AGENT FOR STIMULATING REPRODUCTIVE FUNCTION | 2014 |
|
RU2564016C1 |
| TRANSGENIC MOUSE USED FOR INVESTIGATION OF REPARATIVE REGENERATION OF SKIN WOUND | 2023 |
|
RU2823992C1 |
| AGENT FOR TREATING FEMALE INFERTILITY AND INFERTILITY OF FEMALE ANIMALS | 2017 |
|
RU2740922C2 |
| PHARMACEUTICAL COMPOSITION OF PATTERN-RECOGNISING RECEPTOR LIGANDS, METHODS FOR USING IT AS IMMUNOSTIMULANT FOR TREATING INFECTION CAUSED BY BACTERIAL AND VIRAL PATHOGENS, METHOD FOR USING IT AS ADJUVANT OF VACCINES | 2012 |
|
RU2497541C1 |
